<?xml version='1.0' encoding='UTF-8'?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-03-11T10:03:32Z</responseDate>
  <request metadataPrefix="oai_dc" identifier="oai:hiroshima.repo.nii.ac.jp:02003353" verb="GetRecord">https://hiroshima.repo.nii.ac.jp/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:hiroshima.repo.nii.ac.jp:02003353</identifier>
        <datestamp>2025-02-19T12:13:01Z</datestamp>
        <setSpec>1730444908512:1730444911739</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns="http://www.w3.org/2001/XMLSchema" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Tumour necrosis factor α augments the inhibitory effects of CTLA-4-Ig on osteoclast generation from human monocytes via induction of CD80 expression</dc:title>
          <dc:title>Tumour necrosis factor α は CD 80 発現誘導を介して、CTLA4 Igの破骨細胞分化抑制効果を増強する</dc:title>
          <dc:creator>大井, 勝博</dc:creator>
          <dc:creator>Oi, Katsuhiro</dc:creator>
          <dc:description>内容の要旨, 審査の要旨</dc:description>
          <dc:description>博士(医学)</dc:description>
          <dc:description>Doctor of Philosophy in Medical Science</dc:description>
          <dc:description>http://purl.org/coar/resource_type/c_db06</dc:description>
          <dc:description>広島大学</dc:description>
          <dc:description>Hiroshima University</dc:description>
          <dc:date>2020-03-23</dc:date>
          <dc:identifier>甲第8188号</dc:identifier>
          <dc:identifier>https://hiroshima.repo.nii.ac.jp/records/2003353</dc:identifier>
          <dc:language>eng</dc:language>
          <dc:relation>Clinical and Experimental Immunology, 196: 392-402, 2019</dc:relation>
          <dc:relation>https://doi.org/10.1111/cei.13271</dc:relation>
          <dc:rights>open access</dc:rights>
          <dc:rights>(c) 2019 British Society for Immunology</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
